{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:39:56Z","timestamp":1793695196795,"version":"4.5.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T00:00:00Z","timestamp":1566345600000},"content-version":"vor","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ijpddr.2019.08.004","type":"journal-article","created":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T17:00:18Z","timestamp":1566406818000},"page":"125-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Evaluation of synergy between host and pathogen-directed therapies against intracellular Leishmania donovani"],"prefix":"10.1016","volume":"10","author":[{"given":"M. Shamim Hasan","family":"Zahid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Robert J.","family":"Tokarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay R.","family":"Satoskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Bachelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristy M.","family":"Ainslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2019.08.004_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-7012(99)00051-2","article-title":"Comparison of different staining procedures for the flow cytometric analysis of U-937 cells infected with different Leishmania-species","volume":"37","author":"Abdullah","year":"1999","journal-title":"J.\u00a0Microbiol. Methods"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.ijpddr.2019.08.004_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jac\/49.suppl_1.21","article-title":"AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience","volume":"49","author":"Adler-Moore","year":"2002","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib3","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1021\/cb100399x","article-title":"Identification, in\u00a0vitro activity and mode of action of phosphoinositide-dependent-1 kinase inhibitors as antifungal molecules","volume":"6","author":"Baxter","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib4","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1074\/jbc.M109.036343","article-title":"TLR2 activation is essential to induce a Th1 shift in human peripheral blood mononuclear cells by plant stanols and plant sterols","volume":"285","author":"Brull","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib5","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1128\/AAC.41.4.818","article-title":"An axenic amastigote system for drug screening","volume":"41","author":"Callahan","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib6","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1128\/AAC.00555-09","article-title":"Eradication of intracellular Salmonella enterica serovar Typhimurium with a small-molecule, host cell-directed agent","volume":"53","author":"Chiu","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1423-0127-16-110","article-title":"Eradication of intracellular Francisella tularensis in THP-1 human macrophages with a novel autophagy inducing agent","volume":"16","author":"Chiu","year":"2009","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib9","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1586\/14787210.2013.845524","article-title":"Delivery of host cell-directed therapeutics for intracellular pathogen clearance","volume":"11","author":"Collier","year":"2013","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijpharm.2016.01.004","article-title":"Host-mediated Leishmania donovani treatment using AR-12 encapsulated in acetalated dextran microparticles","volume":"499","author":"Collier","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis","volume":"19","author":"Croft","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib12","doi-asserted-by":"crossref","first-page":"e1253","DOI":"10.1371\/journal.pntd.0001253","article-title":"A\u00a0screen against Leishmania intracellular amastigotes: comparison to a promastigote screen and identification of a host cell-specific hit","volume":"5","author":"De Muylder","year":"2011","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib13","doi-asserted-by":"crossref","first-page":"642502","DOI":"10.1155\/2009\/642502","article-title":"Sterol biosynthesis pathway as target for anti-trypanosomatid drugs","volume":"2009","author":"de Souza","year":"2009","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"10.1016\/j.ijpddr.2019.08.004_bib14","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1128\/AAC.41.5.1064","article-title":"Pentostam induces resistance to antimony and the preservative chlorocresol in Leishmania donovani promastigotes and axenically grown amastigotes","volume":"41","author":"Ephros","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpddr.2012.01.003","article-title":"Visceral leishmaniasis treatment: what do we have, what do we need and how to deliver it?","volume":"2","author":"Freitas-Junior","year":"2012","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.ijpddr.2019.08.004_bib16","first-page":"27","article-title":"Visceral leishmaniasis: experimental models for drug discovery","volume":"133","author":"Gupta","year":"2011","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib17","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ijpharm.2014.10.022","article-title":"Acetalated dextran encapsulated AR-12 as a host-directed therapy to control Salmonella infection","volume":"477","author":"Hoang","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib18","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1128\/AAC.02228-15","article-title":"Needle-free delivery of acetalated dextran-encapsulated AR-12 protects mice from Francisella tularensis Lethal challenge","volume":"60","author":"Hoang","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.molbiopara.2005.12.009","article-title":"Expression profiling by whole-genome interspecies microarray hybridization reveals differential gene expression in procyclic promastigotes, lesion-derived amastigotes, and axenic amastigotes in Leishmania mexicana","volume":"146","author":"Holzer","year":"2006","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/2193-1801-2-55","article-title":"Resazurin-based assay for screening bacteria for radiation sensitivity","volume":"2","author":"Hudman","year":"2013","journal-title":"SpringerPlus"},{"key":"10.1016\/j.ijpddr.2019.08.004_bib21","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2958.2008.06154.x","article-title":"Crucial role of cytosolic tryparedoxin peroxidase in Leishmania donovani survival, drug response and virulence","volume":"68","author":"Iyer","year":"2008","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib22","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.pt.2006.06.012","article-title":"Phlebotomine sand flies and Leishmania parasites: friends or foes?","volume":"22","author":"Kamhawi","year":"2006","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0022-1759(90)90334-R","article-title":"A\u00a0modified colorimetric assay of macrophage activation for intracellular cytotoxicity against Leishmania parasites","volume":"127","author":"Kiderlen","year":"1990","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.ijpddr.2019.08.004_bib24","doi-asserted-by":"crossref","first-page":"R796","DOI":"10.1186\/bcr1294","article-title":"Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours","volume":"7","author":"Kucab","year":"2005","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib25","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s00436-012-3212-3","article-title":"Validation of a simple resazurin-based promastigote assay for the routine monitoring of miltefosine susceptibility in clinical isolates of Leishmania donovani","volume":"112","author":"Kulshrestha","year":"2013","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib26","first-page":"475","article-title":"High-throughput screening of amastigotes of Leishmania donovani clinical isolates against drugs using a colorimetric beta-lactamase assay","volume":"47","author":"Mandal","year":"2009","journal-title":"Indian J. Exp. Biol."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.watres.2006.10.002","article-title":"Development and application of a resazurin-based biomass activity test for activated sludge plant management","volume":"41","author":"McNicholl","year":"2007","journal-title":"Water Res."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1383-5769(99)00020-3","article-title":"A\u00a0simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue","volume":"48","author":"Mikus","year":"2000","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib29","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.exppara.2013.08.004","article-title":"Miltefosine resistance in Leishmania donovani involves suppression of oxidative stress-induced programmed cell death","volume":"135","author":"Mishra","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib30","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1128\/AAC.47.8.2513-2517.2003","article-title":"Immunoenhancement combined with amphotericin B as treatment for experimental visceral leishmaniasis","volume":"47","author":"Murray","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001674","article-title":"Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial","volume":"6","author":"Musa","year":"2012","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib32","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/jac\/14.5.463","article-title":"An in-vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovani","volume":"14","author":"Neal","year":"1984","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib33","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.2353\/ajpath.2010.100367","article-title":"Activation of phosphatidylinositol 3-kinase\/Akt and impairment of nuclear factor-kappaB: molecular mechanisms behind the arrested maturation\/activation state of Leishmania infantum-infected dendritic cells","volume":"177","author":"Neves","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib34","doi-asserted-by":"crossref","first-page":"5421","DOI":"10.1046\/j.1432-1327.2000.01606.x","article-title":"Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity","volume":"267","author":"O'Brien","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003363","article-title":"Using a non-image-based medium-throughput assay for screening compounds targeting N-myristoylation in intracellular Leishmania amastigotes","volume":"8","author":"Paape","year":"2014","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib36","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.vaccine.2008.01.023","article-title":"Vaccines for leishmaniasis in the fore coming 25 years","volume":"26","author":"Palatnik-de-Sousa","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.ijpddr.2019.08.004_bib37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.phytochem.2012.06.012","article-title":"Sterols with antileishmanial activity isolated from the roots of Pentalinon andrieuxii","volume":"82","author":"Pan","year":"2012","journal-title":"Phytochemistry"},{"key":"10.1016\/j.ijpddr.2019.08.004_bib38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drup.2006.04.001","article-title":"Mechanisms of experimental resistance of Leishmania to miltefosine: implications for clinical use","volume":"9","author":"Perez-Victoria","year":"2006","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.ijpddr.2019.08.004_bib39","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1462-5822.2011.01593.x","article-title":"Quantitative proteome profiling informs on phenotypic traits that adapt Leishmania donovani for axenic and intracellular proliferation","volume":"13","author":"Pescher","year":"2011","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib40","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1128\/AAC.00030-11","article-title":"Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani","volume":"56","author":"Purkait","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib41","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0035-9203(03)90167-2","article-title":"Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline","volume":"97","author":"Rijal","year":"2003","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib42","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1462-5822.2006.00769.x","article-title":"Leishmania promastigotes activate PI3K\/Akt signalling to confer host cell resistance to apoptosis","volume":"9","author":"Ruhland","year":"2007","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ymeth.2007.01.006","article-title":"Microtitre plate-based antibacterial assay incorporating resazurin as an indicator of cell growth, and its application in the in\u00a0vitro antibacterial screening of phytochemicals","volume":"42","author":"Sarker","year":"2007","journal-title":"Methods"},{"key":"10.1016\/j.ijpddr.2019.08.004_bib44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/AAC.50.1.73-79.2006","article-title":"In\u00a0vitro and in\u00a0vivo interactions between miltefosine and other antileishmanial drugs","volume":"50","author":"Seifert","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijantimicag.2007.05.007","article-title":"Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in\u00a0vivo","volume":"30","author":"Seifert","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.ijpddr.2019.08.004_bib46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.parint.2006.09.001","article-title":"Advances and perspectives in Leishmania cell based drug-screening procedures","volume":"56","author":"Sereno","year":"2007","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib47","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1128\/AAC.41.5.972","article-title":"Axenically cultured amastigote forms as an in\u00a0vitro model for investigation of antileishmanial agents","volume":"41","author":"Sereno","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib48","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/jat\/8.6.273","article-title":"An enzymatic method for the analysis of formate in human plasma","volume":"8","author":"Shahangian","year":"1984","journal-title":"J.\u00a0Anal. Toxicol."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib49","doi-asserted-by":"crossref","first-page":"666","DOI":"10.4269\/ajtmh.1993.48.666","article-title":"Immunochemotherapy for visceral leishmaniasis: a controlled pilot trial of antimony versus antimony plus interferon-gamma","volume":"48","author":"Squires","year":"1993","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib50","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/0974-777X.62886","article-title":"Liposomal amphotericin B and leishmaniasis: dose and response","volume":"2","author":"Sundar","year":"2010","journal-title":"J.\u00a0Glob. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14656566.2013.755515","article-title":"Leishmaniasis: an update of current pharmacotherapy","volume":"14","author":"Sundar","year":"2013","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib52","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/591972","article-title":"New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine","volume":"47","author":"Sundar","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib53","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/516526","article-title":"Response to interferon-gamma plus pentavalent antimony in Indian visceral leishmaniasis","volume":"176","author":"Sundar","year":"1997","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib54","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0005-2736(87)90443-3","article-title":"Spin-labeled amphotericin B: synthesis, characterization, biological and spectroscopic properties","volume":"897","author":"Urbina","year":"1987","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijpddr.2019.08.004_bib55","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.4049\/jimmunol.0803859","article-title":"Miltefosine promotes IFN-gamma-dominated anti-leishmanial immune response","volume":"182","author":"Wadhone","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib56","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.179.4.1367","article-title":"CD4+ effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major","volume":"179","author":"Wang","year":"1994","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.ijpddr.2019.08.004_bib57","article-title":"Bone marrow-derived macrophages (BMM): isolation and applications","volume":"3","author":"Weischenfeldt","year":"2008","journal-title":"CSH Protoc"},{"key":"10.1016\/j.ijpddr.2019.08.004_bib58","series-title":"Leishmaniasis Fact Sheet","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.ijpddr.2019.08.004_bib59","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1080\/15384101.2018.1467677","article-title":"Autophagy inhibition enhances celecoxib-induced apoptosis in osteosarcoma","volume":"17","author":"Zhou","year":"2018","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ijpddr.2019.08.004_bib60","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.drudis.2017.06.004","article-title":"Leishmaniasis drug discovery: recent progress and challenges in assay development","volume":"22","author":"Zulfiqar","year":"2017","journal-title":"Drug Discov. Today"}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320719300867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320719300867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:48:58Z","timestamp":1761922138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320719300867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":60,"alternative-id":["S2211320719300867"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2019.08.004","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of synergy between host and pathogen-directed therapies against intracellular Leishmania donovani","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2019.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}